fabomotizole

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namefabomotizole
Drug Alias NameafobazoleafobazolaphobazoleobenoxazineSM-346 +[7] 
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsSigma-2 receptor agonists
TargetsSigma-2 receptor
Therapy Area/IndicationsIschemic StrokeNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesState Foundation Institute of Pharmacology RAMS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesState Foundation Institute of Pharmacology RAMSPharmstandardInternational Biotechnology Center Generium Llc +[4] 
Active IndicationsN/A
Inactive IndicationsIschemic StrokeNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A